Multidrug-resistant organisms - Epidemiology, surveillance and importance;Multiresistente Erreger - Epidemiologie, Surveillance und Bedeutung

Anasthesiologie Intensivmedizin Notfallmedizin Schmerztherapie

Volumn 51, Issue 2, 2016, Pages 104-110

  Geffers, Christine ^a   Maechler, Friederike ^a   Behnke, Michael ^a   Gastmeier, Petra ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE SURVEILLANCE; MULTIDRUG RESISTANCE; NONHUMAN; REVIEW; BACTERIAL INFECTIONS; CROSS INFECTION; DISEASE NOTIFICATION; DRUG EFFECTS; EPIDEMIOLOGY; GERMANY; HEALTH SURVEY; HUMAN; INCIDENCE; MANDATORY REPORTING; MORTALITY; PREVALENCE; PROCEDURES; RISK FACTOR; SURVIVAL RATE;

ANTIINFECTIVE AGENT;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CROSS INFECTION; DISEASE NOTIFICATION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GERMANY; HUMANS; INCIDENCE; MANDATORY REPORTING; POPULATION SURVEILLANCE; PREVALENCE; RISK FACTORS; SURVIVAL RATE;

EID: 84960091482     PISSN: 09392661     EISSN: 14391074     Source Type: Journal    
DOI: 10.1055/s-0041-103348     Document Type: Review

References (16)

1. Gastmeier P., Schroder C., Behnke M. et al. Dramatic increase in vancomycin-resistant enterococci in Germany. J Antimicrob Chemother: 2014; 69 1660 1664
2. Robert Koch-Institut ARS https://www.ars.rki.de Stand 01.07.2015
3. Herrmann M., Petit C., Dawson A. et al. Methicillin-resistant Staphylococcus aureus in Saarland, Germany: a statewide admission prevalence screening study. PloS one: 2013; 8
4. Pohle M., Bär W., Bühling A. et al. Untersuchung der MRSA-Prävalenz in der Bevölkerung im Bereich des lokalen MRE-Netzwerkes Südbrandenburg. Epid Bull: 2012; 8 63 67
5. Hygienemaβnahmen bei Infektionen oder Besiedlung mit multiresistenten gramnegativen Stäbchen. Bundesgesundheitsbl: 2012; 55 1311 1354
6. Zuschneid I., Schwab F., Geffers C. et al. Reducing central venous catheter-associated primary bloodstream infections in intensive care units is possible: data from the German nosocomial infection surveillance system. Infect Control Hosp Epidemiol: 2003; 24 501 505
7. Gastmeier P., Sohr D., Schwab F. et al. Ten years of KISS: the most important requirements for success. J Hosp Infect: 2008; 70 01 11 16
8. Schwab F., Geffers C., Barwolff S. et al. Reducing neonatal nosocomial bloodstream infections through participation in a national surveillance system. J Hosp Infect: 2007; 65 319 325
9. Schroder C., Schwab F., Behnke M. et al. Epidemiology of healthcare associated infections in Germany: Nearly 20 years of surveillance. International journal of medical microbiology. Int J Med Microbiol: 2015; 305 799 806
10. Mitteilung der Kommission für Krankenhaushygiene und Infektionsprävention zur Surveillance (Erfassung und Bewertung) von nosokomialen Infektionen (Umsetzung von § 23 IfSG). Bundesgesundheitsbl: 2001; 44 523 536
11. Surveillance nosokomialer Infektionen sowie die Erfassung von Erregern mit speziellen Resistenzen und Multiresistenzen. Bundesgesundheitsbl: 2013; 56 580 583
12. Robert Koch-Institut Zur Surveillance der Antibiotikaresistenz in Deutschland. Epid Bull: 2007; 44 405 409
13. Meyer E., Jonas D., Schwab F. et al. SARI: Surveillance der Antibiotikaanwendung und bakteriellen Resistenzentwicklung auf deutschen Intensivstationen. Bundesgesundheitsbl: 2004; 47 345 351
14. Gastmeier P., Schwab F., Chaberny I. et al. Individual units rather than entire hospital as the basis for improvement: the example of two Methicillin resistant Staphylococcus aureus cohort studies. Antimicrob Resist Control: 2012; 1 8 8
15. Hanberger H., Walther S., Leone M. et al. Increased mortality associated with methicillin-resistant Staphylococcus aureus (MRSA) infection in the intensive care unit: results from the EPIC II study. Int J Antimicrob Agents: 2011; 38 331 335
16. Tansarli G. S., Karageorgopoulos D. E., Kapaskelis A. et al. Impact of antimicrobial multidrug resistance on inpatient care cost: an evaluation of the evidence. Expert Rev Anti Infect Ther: 2013; 11 321 331